June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Corneal Fungal Infections: Evaluation and Treatment.
Author Affiliations & Notes
  • Davide Borroni
    Ophthalmology, Riga Stradins University, Riga, Latvia
  • Araniko Pandey
    Cornea, Lumbini Eye Institute , Lumbini , Nepal
  • Ilze Lace
    Ophthalmology, Riga Stradins University, Riga, Latvia
  • Eva Drucka
    Ophthalmology, Riga Stradins University, Riga, Latvia
  • Arturs Zemitis
    Ophthalmology, Riga Stradins University, Riga, Latvia
  • Footnotes
    Commercial Relationships   Davide Borroni, None; Araniko Pandey, None; Ilze Lace, None; Eva Drucka, None; Arturs Zemitis, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3885. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Davide Borroni, Araniko Pandey, Ilze Lace, Eva Drucka, Arturs Zemitis; Corneal Fungal Infections: Evaluation and Treatment.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3885.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Corneal ulcer due to Fungal Infection is a major cause of blindness in agricultural areas of Nepal. We evaluated the characteristics of 158 patients with fungal keratitis at Lumbini Eye Institute (Nepal) and its medical treatments.

Methods : First diagnosis of fungal infection was performed to slit-lamp examination plus Potassium Hydroxide (KOH) procedure placing specimiens in a 15% KOH solution (15g KOH, glycerol 20ml, distilled water 80ml). Antifungal drops were used every half to one hourly initially and tapered as per the clinical response. Natamycin 5% and Amphotericin B 0.15% were the first choice of treatment. Other drops used in selective cases were topical 1% voriconazole, topical 2% econazole, topical 1% itraconazole, topical 2% fluconazole. Surface debridement was considered in 47 cases. Atropine and FANS (Diclofenac) were integrated in the management.

Results : Fungal infections of the cornea were frequently caused by Fusarium, Aspergillus, Curvularia, and Candida. Trauma was the most important predisposing cause 128/158 (81,01%). Surface debridement helped to reduce load of infection and enhanced drug penetration. Response to treatment in fungal infections is very slow and complete resolution often required 4-8 weeks of treatment.

Conclusions : Natamycin and amphotericin B were the most used drugs for fungal keratitis who showed good clinical results. Voriconazole showed effectiveness and security and it may be the drug of choice in optimal conditions for its better ocular penetration and wider coverage but the high price per unit pone difficulties in general applications. Fluconazole has high corneal penetration and reaches therapeutic corneal levels when given orally. Its clinical role in filamentous fungal keratitis is yet to be precisely defined; however, it could be considered in patients with deep fungal keratitis.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.